Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived

MeSH terms

• Acute Disease
• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Cytarabine / administration & dosage
• Female
• Humans
• Induction Chemotherapy / methods
• Leukemia, Myeloid / drug therapy*
• Leukemia, Myeloid / pathology
• Male
• Middle Aged
• Remission Induction
• Survival Analysis
• Young Adult